Saito Nozomi, Matsunaga Toshihiro, Fujishima Toshie, Anzai Miyuki, Saito Hiroshi, Takenouchi Kazuya, Miura Daishiro, Ishizuka Seiichi, Takayama Hiroaki, Kittaka Atsushi
Faculty of Pharmaceutical Sciences, Teikyo University, Kanagawa 199-0195, Japan.
Org Biomol Chem. 2003 Dec 21;1(24):4396-402. doi: 10.1039/b311107e. Epub 2003 Nov 6.
Novel 2[small alpha]-methyl-, 2[small alpha]-(3-hydroxypropyl)- and 2[small alpha]-(3-hydroxypropoxy)-substituted 25-dehydro-1[small alpha]-hydroxyvitamin D-26,23-lactone derivatives were efficiently synthesized Reformatsky type allylation and palladium-catalyzed alkenylative cyclization processes, and their biological activities were evaluated. Introducing functional groups into the 2[small alpha]-position of the vitamin D-26,23-lactones resulted in remarkable enhancement of their antagonistic activity on vitamin D receptor (VDR).
通过Reformatsky型烯丙基化反应和钯催化的烯基化环化反应高效合成了新型的2[小α]-甲基、2[小α]-(3-羟丙基)和2[小α]-(3-羟丙氧基)取代的25-脱氢-1[小α]-羟基维生素D-26,23-内酯衍生物,并对其生物活性进行了评估。在维生素D-26,23-内酯的2[小α]位引入官能团导致其对维生素D受体(VDR)的拮抗活性显著增强。